Medicare Enrolled
Dr. Kristen Gonter-Aubin, D.O.
Internal Medicine · North Venice, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gonter-Aubin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gonter-Aubin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gonter-Aubin
Dr. Kristen Gonter-Aubin is an internal medicine specialist in North Venice, FL, with 12 years of NPI registration. Based on federal Medicare data, Dr. Gonter-Aubin performed 208,641 Medicare services across 5,315 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gonter-Aubin received a total of $10,012 from 70 pharmaceutical and/or device companies across 446 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gonter-Aubin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 0% volume in FL
$10,012 industry payments
Medicare Practice Summary
Medicare Utilization ↗208,641
Medicare services
Top 0% in FL for internal medicine
5,315
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~17,387 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 47,430 | $0 | $4 |
| Iron sucrose injection (Venofer) | 17,400 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 17,000 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 16,510 | $1 | $5 |
| Paclitaxel chemotherapy injection | 15,861 | $0 | $2 |
| Nivolumab injection (Opdivo) | 15,580 | $24 | $72 |
| Daratumumab injection (Darzalex) | 11,700 | $38 | $110 |
| Azacitidine chemotherapy injection | 8,400 | $0 | $4 |
| Denosumab injection (Prolia/Xgeva) | 7,800 | $18 | $51 |
| Filgrastim injection (Zarxio) for white blood cells | 7,020 | $0 | $2 |
| Immune globulin infusion (Gammagard) | 6,966 | $36 | $108 |
| Epoetin alfa injection (Procrit) for anemia | 6,680 | $6 | $23 |
| Injection, docetaxel, 1 mg | 4,159 | $0 | $7 |
| Dexamethasone injection (steroid) | 3,896 | $0 | $3 |
| Complete blood count (CBC) with differential | 2,923 | $8 | $29 |
| Blood draw (venipuncture) | 2,770 | $8 | $9 |
| Iron infusion (Monoferric) | 2,700 | $17 | $57 |
| Injection, eflapegrastim-xnst, 0.1 mg | 2,244 | $26 | $116 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,990 | $1 | $28 |
| Injection of additional new drug or substance into vein | 936 | $12 | $61 |
| Office visit, established patient (20-29 min) | 875 | $65 | $239 |
| Anti-nausea injection (ondansetron/Zofran) | 872 | $0 | $9 |
| Drug injection, under skin or into muscle | 759 | $10 | $69 |
| Office visit, established patient (30-39 min) | 716 | $96 | $339 |
| Administration of chemotherapy into vein, 1 hour or less | 582 | $97 | $378 |
| Injection, carboplatin, 50 mg | 434 | $2 | $41 |
| Cyclophosphamide, 100 mg | 434 | $16 | $79 |
| Injection, zoledronic acid, 1 mg | 372 | $7 | $69 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 361 | $47 | $189 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 333 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 252 | $21 | $84 |
| Injection, diphenhydramine hcl, up to 50 mg | 252 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 223 | $15 | $56 |
| Administration of chemotherapy into vein, each additional hour | 223 | $22 | $79 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 214 | $16 | $59 |
| Administration of additional new drug or substance into vein, 1 hour or less | 185 | $49 | $178 |
| Infusion, normal saline solution , 1000 cc | 147 | $2 | $7 |
| Infusion into a vein for hydration, each additional hour | 138 | $10 | $42 |
| Red blood count automated, with additional calculations | 133 | $5 | $20 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 131 | $53 | $206 |
| Injection of drug or substance into vein | 116 | $28 | $156 |
| Injection, magnesium sulfate, per 500 mg | 109 | $1 | $2 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 92 | $3 | $11 |
| Office visit, established patient, complex (40-54 min) | 75 | $135 | $474 |
| New patient office visit, complex (60-74 min) | 71 | $170 | $585 |
| Infusion into a vein for hydration, 31-60 minutes | 62 | $25 | $156 |
| Hospital follow-up visit, moderate complexity | 61 | $62 | $197 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 61 | $133 | $562 |
| New patient office visit (45-59 min) | 59 | $124 | $453 |
| Automated urinalysis | 50 | $2 | $8 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 47 | $24 | $89 |
| Administration of additional new drug or substance into vein using push technique | 46 | $42 | $170 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 45 | $1 | $7 |
| Drawing of blood for a medical problem | 42 | $66 | $277 |
| Prothrombin time test (blood clotting) | 31 | $4 | $15 |
| Office visit, established patient (10-19 min) | 31 | $37 | $147 |
| Initial hospital admission, high complexity | 28 | $136 | $556 |
| New patient office visit (30-44 min) | 14 | $88 | $298 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
28.0% high complexity
67.8% medium
4.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,012
Total received (2019-2024)
Avg $1,669/year across 6 years
Top 7% in FL for internal medicine
70
Companies
446
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,854 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$158 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,184
2023
$2,840
2022
$2,740
2021
$698
2020
$185
2019
$366
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$848
AstraZeneca Pharmaceuticals LP
$689
Novartis Pharmaceuticals Corporation
$677
Janssen Biotech, Inc.
$559
Daiichi Sankyo Inc.
$473
Celgene Corporation
$467
Merck Sharp & Dohme LLC
$418
Gilead Sciences, Inc.
$407
Genentech USA, Inc.
$334
BeiGene USA, Inc.
$334
PFIZER INC.
$327
Lilly USA, LLC
$313
Takeda Pharmaceuticals U.S.A., Inc.
$267
Incyte Corporation
$257
Seagen Inc.
$255
GlaxoSmithKline, LLC.
$201
Acrotech Biopharma Inc.
$158
Astellas Pharma US Inc
$148
Kite Pharma, Inc.
$146
Amgen Inc.
$145
SOBI, INC
$138
Regeneron Healthcare Solutions, Inc.
$125
GENZYME CORPORATION
$125
ARRAY BIOPHARMA INC
$125
Eisai Inc.
$119
Exelixis Inc.
$98
Bayer Healthcare Pharmaceuticals Inc.
$96
PharmaEssentia USA Corporation
$79
Sumitomo Pharma America, Inc.
$78
Bayer HealthCare Pharmaceuticals Inc.
$75
Alexion Pharmaceuticals, Inc.
$74
JAZZ PHARMACEUTICALS INC.
$74
ABBVIE INC.
$70
Rigel Pharmaceuticals, Inc.
$69
Stemline Therapeutics Inc.
$66
Karyopharm Therapeutics Inc.
$61
PUMA BIOTECHNOLOGY, INC.
$60
Merck Sharp & Dohme Corporation
$59
EMD Serono, Inc.
$56
Seattle Genetics, Inc.
$55
Dova Pharmaceuticals
$55
ADC Therapeutics America, Inc.
$49
Myovant Sciences Inc.
$49
Pharmacyclics LLC, An AbbVie Company
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
Mirati Therapeutics, Inc.
$47
EISAI INC.
$44
Kyowa Kirin, Inc.
$44
Dendreon Pharmaceuticals LLC
$44
Deciphera Pharmaceuticals Inc.
$43
AVEO Pharmaceuticals, Inc.
$38
Sobi, Inc
$36
Genmab U.S., Inc.
$27
Legend Biotech USA Inc.
$25
Coherus Biosciences Inc.
$24
G1 Therapeutics, Inc.
$23
Epizyme, Inc.
$21
RECORDATI_RARE_DISEASES_INC.
$20
Aveo Pharmaceuticals, Inc.
$20
EUSA Pharma (US) LLC
$20
Blueprint Medicines Corporation
$19
GE HealthCare
$19
Jazz Pharmaceuticals Inc.
$18
CTI BioPharma Corp.
$18
Alnylam Pharmaceuticals Inc.
$17
TAIHO ONCOLOGY, INC.
$17
MorphoSys, US Inc.
$16
Agios Pharmaceuticals, Inc.
$15
Epizyme, Inc.,
$15
Pharmacosmos Therapeutics Inc.
$13
Top 3 companies account for 22.1% of total payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Alecensa · Avastin · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · Enhertu · Epkinly · Erleada · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · Nubeqa · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RYBREVANT · SCEMBLIX · SHINGRIX · SYLVANT · Stivarga · Sylvant · TASIGNA · TAZVERIK · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tazverik · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vonjo · XALKORI · XGEVA · XPOVIO · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for internal medicine in FL.
Equivalent to $5 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
483
Per 100K population
107.6
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL - VENICE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gonter-Aubin is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), with low-engagement industry engagement in the top 7% of FL peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gonter-Aubin experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Gonter-Aubin performed 47,430 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gonter-Aubin receive payments from pharmaceutical companies?
Yes. Dr. Gonter-Aubin received a total of $10,012 from 70 companies across 446 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gonter-Aubin's costs compare to other internal medicine physicians in North Venice?
Dr. Gonter-Aubin's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gonter-Aubin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in North Venice
Browse internal medicine physicians in North Venice ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in FL
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in FL
Which FL internal medicine physicians receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology